A cannabis extract has shown positive results in slowing down melanoma cell growth.
A new case study highlights the potential of cannabis for improving quality of life in patients with neuropathic pain.
Zurich will be the second Swiss city to legalise the sale and consumption of limited amounts of cannabis for personal use.
The Cannabis Industry Council (CIC), has called on the ACMD to recommend to the Home Office that cannabis be rescheduled for research purposes.
Advocates in the UK are calling for their own government to follow suit and invest in much-needed NHS trials.
One in two patients were prescribed medicinal cannabis for chronic pain, with a quarter taking it to treat mental health conditions.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.
The changes are expected to make it easier for patients to access the treatment in a ‘timely’ and ‘needs-based manner'.
Around 60% of patients with Parkinson’s disease and multiple sclerosis said cannabis was beneficial at managing their symptoms.
F1 hybrid seeds by RQS are being touted as the “future” of cannabis.
Julie Durrans, co-founder of the Tiny Cannabis Club, on how she reclaimed her health with cannabis.